EPAM vs MIRA · P/E 14, rev $2.81B vs $41.1M cap
EPAM Systems Inc (EPAM) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
MIRA does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the EPAM and MIRA stock pages for the full models.
Not investment advice.